773 related articles for article (PubMed ID: 18195264)
1. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
[TBL] [Abstract][Full Text] [Related]
4. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
5. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
[TBL] [Abstract][Full Text] [Related]
6. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
[TBL] [Abstract][Full Text] [Related]
7. MRI predictors of risk of incident Alzheimer disease: a longitudinal study.
Stoub TR; Bulgakova M; Leurgans S; Bennett DA; Fleischman D; Turner DA; deToledo-Morrell L
Neurology; 2005 May; 64(9):1520-4. PubMed ID: 15883311
[TBL] [Abstract][Full Text] [Related]
8. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.
Tapiola T; Pennanen C; Tapiola M; Tervo S; Kivipelto M; Hänninen T; Pihlajamäki M; Laakso MP; Hallikainen M; Hämäläinen A; Vanhanen M; Helkala EL; Vanninen R; Nissinen A; Rossi R; Frisoni GB; Soininen H
Neurobiol Aging; 2008 Jan; 29(1):31-8. PubMed ID: 17097769
[TBL] [Abstract][Full Text] [Related]
9. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
10. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
deToledo-Morrell L; Stoub TR; Bulgakova M; Wilson RS; Bennett DA; Leurgans S; Wuu J; Turner DA
Neurobiol Aging; 2004 Oct; 25(9):1197-203. PubMed ID: 15312965
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
12. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.
Stoub TR; Rogalski EJ; Leurgans S; Bennett DA; deToledo-Morrell L
Neurobiol Aging; 2010 Jul; 31(7):1089-98. PubMed ID: 18809228
[TBL] [Abstract][Full Text] [Related]
13. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
[TBL] [Abstract][Full Text] [Related]
14. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
15. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
16. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
18. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
[TBL] [Abstract][Full Text] [Related]
19. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
[TBL] [Abstract][Full Text] [Related]
20. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.
Devanand DP; Liu X; Tabert MH; Pradhaban G; Cuasay K; Bell K; de Leon MJ; Doty RL; Stern Y; Pelton GH
Biol Psychiatry; 2008 Nov; 64(10):871-9. PubMed ID: 18723162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
